A detailed history of Stanley Laman Group, Ltd. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 65,336 shares of LNTH stock, worth $7.19 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares
65,336
Previous 76,347 14.42%
Holding current value
$7.19 Million
Previous $6.13 Million 16.98%
% of portfolio
1.11%
Previous 0.96%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$77.7 - $123.62 $855,554 - $1.36 Million
-11,011 Reduced 14.42%
65,336 $7.17 Million
Q2 2024

Jul 18, 2024

BUY
$58.87 - $83.05 $17,248 - $24,333
293 Added 0.39%
76,347 $6.13 Million
Q1 2024

Apr 17, 2024

BUY
$51.07 - $68.26 $850,315 - $1.14 Million
16,650 Added 28.03%
76,054 $4.73 Million
Q4 2023

Feb 02, 2024

BUY
$55.6 - $77.89 $3.3 Million - $4.63 Million
59,404 New
59,404 $3.68 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.57B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Stanley Laman Group, Ltd. Portfolio

Follow Stanley Laman Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.